Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.

JCO precision oncology - 1 Jul 2021

Larson Kara L, Huang Bin, Weiss Heidi L, Hull Pam, Westgate Philip M, Miller Rachel W, Arnold Susanne M, Kolesar Jill M

Abstract excerpt

We conducted this systematic review to evaluate the clinical outcomes associated with molecular tumor board (MTB) review in patients with cancer. METHODS: A systematic search of PubMed was performed to identify studies reporting clinical outcomes in patients with cancer who were reviewed by an MTB. To be included, studies had to report clinical outcomes, including clinical benefit, response, progression-free...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Decision-Making

Share to High-Throughput Nucleotide Sequencing

Share to Medical Oncology

Share to Molecular Targeted Therapy

Share to Patient Care Team

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 34632252
DOI: 10.1200/PO.20.00495
PMCID: PMC8277300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review.PMID 34632252Read ↗

Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer.Semantic proximity Read ↗

Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.Semantic proximity Read ↗

The molecular tumor board—a key element of precision oncologySemantic proximity Read ↗

Molecular Tumor Board: The University of California San Diego Moores Cancer Center ExperienceSemantic proximity Read ↗

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical CenterSemantic proximity Read ↗

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.Semantic proximity Read ↗

The Molecular Tumor Board of the Regina Elena National Cancer Institute: from accrual to treatment in real-world.Semantic proximity Read ↗

Patient attrition in Molecular Tumour Boards: A ReviewSemantic proximity Read ↗

Molecular Tumor Board of the University Medical Center Groningen (UMCG-MTB): outcome of patients with rare or complex mutational profiles receiving MTB-advised targeted therapy.Semantic proximity Read ↗

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.Semantic proximity Read ↗

Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.Semantic proximity Read ↗

What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.